Petros Pharmaceuticals, Inc. (PTPI)
USD 0.04
(1.75%)
USD 0.04
(1.75%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -4.21 Million USD | -7.37% |
| 2022 | -13.72 Million USD | 38.74% |
| 2021 | -1.63 Million USD | -5.16% |
| 2020 | -12.2 Million USD | 8.25% |
| 2019 | -13.99 Million USD | -2891.56% |
| 2018 | 373.57 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -1.56 Million USD | -193.48% |
| 2024 Q2 | -1.52 Million USD | 116.07% |
| 2023 Q2 | -1.58 Million USD | -280.38% |
| 2023 Q3 | -3.97 Million USD | -151.4% |
| 2023 FY | - USD | -7.37% |
| 2023 Q4 | -3.87 Million USD | 2.6% |
| 2023 Q1 | -416.18 Thousand USD | 86.87% |
| 2022 FY | - USD | 38.74% |
| 2022 Q4 | -3.17 Million USD | 31.83% |
| 2022 Q3 | -4.65 Million USD | -4525.71% |
| 2022 Q2 | -100.55 Thousand USD | -109.31% |
| 2022 Q1 | 1.07 Million USD | 117.19% |
| 2021 FY | - USD | -5.16% |
| 2021 Q4 | -6.28 Million USD | -236.32% |
| 2021 Q3 | -1.86 Million USD | 26.81% |
| 2021 Q2 | -2.55 Million USD | -444.48% |
| 2021 Q1 | -468.67 Thousand USD | 89.16% |
| 2020 FY | - USD | 8.25% |
| 2020 Q4 | -4.32 Million USD | -540.19% |
| 2020 Q3 | -675.05 Thousand USD | 79.89% |
| 2020 Q2 | -3.35 Million USD | 14.97% |
| 2020 Q1 | -3.94 Million USD | 15.11% |
| 2019 Q1 | -564.13 Thousand USD | 0.0% |
| 2019 Q4 | -4.65 Million USD | -26.26% |
| 2019 FY | - USD | -2891.56% |
| 2019 Q3 | -3.68 Million USD | -37.51% |
| 2019 Q2 | -2.67 Million USD | -374.85% |
| 2018 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 308.32 Million USD | 101.366% |
| China SXT Pharmaceuticals, Inc. | -2.35 Million USD | -79.152% |
| Embecta Corp. | 245.4 Million USD | 101.716% |
| Pacira BioSciences, Inc. | 162.89 Million USD | 102.586% |
| PainReform Ltd. | -9.56 Million USD | 55.984% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | -10.131% |
| SCYNEXIS, Inc. | 73.47 Million USD | 105.732% |
| Journey Medical Corporation | 1.92 Million USD | 319.254% |
| Safety Shot Inc | -12.18 Million USD | 65.434% |
| Alpha Teknova, Inc. | -25.53 Million USD | 83.508% |
| Bright Green Corporation | - USD | Infinity% |
| Procaps Group, S.A. | 104.02 Million USD | 104.049% |
| Alvotech | -484.86 Million USD | 99.131% |
| ANI Pharmaceuticals, Inc. | 109.32 Million USD | 103.853% |
| Aquestive Therapeutics, Inc. | 1.18 Million USD | 456.334% |
| Cosmos Health Inc. | -17.06 Million USD | 75.314% |
| Dynavax Technologies Corporation | 9.66 Million USD | 143.574% |
| Esperion Therapeutics, Inc. | -150.1 Million USD | 97.194% |
| Intra-Cellular Therapies, Inc. | -158.85 Million USD | 97.349% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | -10.131% |
| Theratechnologies Inc. | -10.31 Million USD | 59.159% |
| Harrow Health, Inc. | 9.72 Million USD | 143.319% |
| Sonoma Pharmaceuticals, Inc. | -4.52 Million USD | 6.92% |
| Biofrontera Inc. | -18.45 Million USD | 77.175% |
| DURECT Corporation | -24.68 Million USD | 82.937% |
| Supernus Pharmaceuticals, Inc. | 98.26 Million USD | 104.286% |
| Cronos Group Inc. | -72.14 Million USD | 94.162% |
| OptiNose, Inc. | -15.55 Million USD | 72.919% |
| Ironwood Pharmaceuticals, Inc. | -924.86 Million USD | 99.545% |
| Kala Pharmaceuticals, Inc. | -36.08 Million USD | 88.327% |
| RedHill Biopharma Ltd. | 26.26 Million USD | 116.035% |
| Organogenesis Holdings Inc. | 36.03 Million USD | 111.69% |
| Guardion Health Sciences, Inc. | -3.92 Million USD | -7.381% |
| Cumberland Pharmaceuticals Inc. | -710.85 Thousand USD | -492.512% |
| Radius Health, Inc. | 38.31 Million USD | 110.994% |
| Universe Pharmaceuticals INC | -3.21 Million USD | -31.004% |
| ProPhase Labs, Inc. | -14.82 Million USD | 71.593% |
| Phibro Animal Health Corporation | 84.6 Million USD | 104.978% |
| Procaps Group S.A. | 104.02 Million USD | 104.049% |
| TherapeuticsMD, Inc. | -8.4 Million USD | 49.865% |
| Viatris Inc. | 3.51 Billion USD | 100.12% |
| Rockwell Medical, Inc. | -4.69 Million USD | 10.271% |
| Aytu BioPharma, Inc. | -1.01 Million USD | -316.193% |
| SIGA Technologies, Inc. | 84.15 Million USD | 105.005% |
| Tilray Brands, Inc. | -72.84 Million USD | 94.218% |
| Lifecore Biomedical, Inc. | 812 Thousand USD | 618.703% |
| Shineco, Inc. | -26.55 Million USD | 84.138% |
| PetIQ, Inc. | 81.48 Million USD | 105.169% |
| Regencell Bioscience Holdings Limited | -3.61 Million USD | -16.426% |
| Incannex Healthcare Limited | -18.5 Million USD | 77.238% |
| Neurocrine Biosciences, Inc. | 416.1 Million USD | 101.012% |
| Alimera Sciences, Inc. | 7.27 Million USD | 157.887% |
| Silver Spike Investment Corp. | 7.34 Million USD | 157.382% |
| Assertio Holdings, Inc. | -222.44 Million USD | 98.107% |
| Shuttle Pharmaceuticals Holdings, Inc. | -3.99 Million USD | -5.544% |
| Clever Leaves Holdings Inc. | -16.8 Million USD | 74.935% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | 78.973% |
| Avadel Pharmaceuticals plc | -149.12 Million USD | 97.176% |
| Hempacco Co., Inc. | -12.77 Million USD | 67.026% |
| Talphera, Inc. | -9.84 Million USD | 57.205% |
| Alvotech | -484.86 Million USD | 99.131% |
| Eagle Pharmaceuticals, Inc. | 77.5 Million USD | 105.435% |
| Lantheus Holdings, Inc. | 491 Million USD | 100.858% |
| Currenc Group, Inc. | -1.9 Million USD | -121.61% |
| Kamada Ltd. | 21.53 Million USD | 119.559% |
| Indivior PLC | 66 Million USD | 106.382% |
| Evoke Pharma, Inc. | -7.29 Million USD | 42.242% |
| Flora Growth Corp. | -45.87 Million USD | 90.818% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | 78.973% |
| Evolus, Inc. | -41.81 Million USD | 89.926% |
| HUTCHMED (China) Limited | 25.52 Million USD | 116.499% |
| Amphastar Pharmaceuticals, Inc. | 241.46 Million USD | 101.744% |
| Akanda Corp. | -27.73 Million USD | 84.814% |